Read More Analyst Ratings News Price Target Mizuho Maintains Buy on Boston Properties, Lowers Price Target to $105 By Benzinga Newsdesk July 6, 8:12 AM Mizuho analyst Vikram Malhotra maintains Boston Properties (NYSE:BXP) with a Buy and lowers the price target from $135 to $105. BXP
Read More Biotech General News GSK Announces AREXVY, Its Respiratory Syncytial Virus Vaccine, Is Now Available At All Major U.S. Retail Pharmacies By Happy Mohamed August 17, 8:07 AM Ahead of the fall and winter RSV season, AREXVY is now widely available in major retail pharmacies and anticipated to be covered by most Medicare and commercial insurance plans GSK plc (NYSE:GSK) today announced that GSK
Read More Biotech General Health Care Large Cap Media News Top Stories British Agency Supports Eli Lilly’s Weight Loss Drug Mounjaro, Diverging From Restrictions on Rival Novo Nordisk’s Wegovy By Vandana Singh June 5, 12:21 PM NICE recommends Eli Lilly's Mounjaro for obesity, omitting time limits applied to Novo Nordisk's Wegovy, opening new avenues for long-term treatment. LLY
Read More Earnings Guidance News Tech Roper Technologies Registers 14% Revenue Growth In Q4; Bottom-Line Beats Street View By Anusuya Lahiri January 27, 10:41 AM Roper Technologies, Inc (NYSE:ROP) reported fourth-quarter FY22 adjusted revenue growth of 14% year-over-year to $1.43 billion, which was in… ROP